Vycor Medical (VYCO) stock price, revenue, and financials

Vycor Medical market cap is $4.1 m, and annual revenue was $1.48 m in FY 2019

$4.1 M

VYCO Mkt cap, 17-Nov-2020

$244.3 K

Vycor Medical Revenue Q2, 2020
Vycor Medical Gross profit (Q2, 2020)223.8 K
Vycor Medical Gross profit margin (Q2, 2020), %91.6%
Vycor Medical Net income (Q2, 2020)-248.9 K
Vycor Medical EBIT (Q2, 2020)-199.4 K
Vycor Medical Cash, 30-Jun-202071 K
Vycor Medical EV4.4 M

Vycor Medical Revenue

Vycor Medical revenue was $1.48 m in FY, 2019

Embed Graph

Vycor Medical Income Statement

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Revenue

142.3k231.3k432.6k265.4k220.1k231.7k235.0k321.6k358.1k298.5k334.3k328.6k286.0k242.9k400.1k379.4k325.8k428.4k307.7k379.1k325.1k301.7k456.2k350.7k429.9k346.3k351.1k244.3k

Cost of goods sold

35.2k36.3k79.4k40.2k25.4k30.0k27.9k41.8k43.0k35.8k47.3k51.7k34.0k26.3k67.2k48.1k37.5k48.0k39.4k55.3k29.3k47.0k46.8k36.2k38.9k31.5k38.9k20.5k

Gross profit

107.1k195.0k353.2k225.1k194.7k201.7k207.1k279.8k315.2k262.8k287.0k276.9k252.0k216.6k332.8k331.3k288.3k380.4k268.2k323.7k295.8k254.7k409.4k314.5k391.0k314.8k312.2k223.8k

Gross profit Margin, %

75%84%82%85%88%87%88%87%88%88%86%84%88%89%83%87%88%89%87%85%91%84%90%90%91%91%89%92%

R&D expense

37.5k33.6k24.7k45.9k33.7k31.4k21.3k15.4k37.4k6.9k23.2k15.7k29.3k4.2k

General and administrative expense

866.8k1.2m1.1m839.4k838.7k683.7k706.1k673.5k1.2m830.0k624.0k779.3k607.8k604.7k784.3k556.5k535.5k610.8k552.9k546.6k568.3k617.0k499.1k462.2k543.5k491.3k453.9k408.5k

Operating expense total

1.9m1.3m1.1m967.9k957.1k801.3k816.7k764.0k1.3m966.4k724.8k885.2k710.1k725.8k847.6k622.8k603.5k680.1k622.1k619.3k610.3k660.3k542.1k477.3k558.3k506.5k468.5k423.1k

Depreciation and amortization

53.6k82.6k84.8k86.3k89.3k90.6k94.1k99.0k93.9k82.6k86.7k91.8k63.3k66.3k63.8k69.4k69.3k72.7k42.0k43.3k43.0k15.1k14.8k15.1k14.6k14.6k

EBIT

(1.8m)(1.1m)(759.9k)(742.7k)(762.4k)(599.6k)(609.6k)(484.2k)(992.5k)(703.6k)(437.8k)(608.3k)(458.1k)(509.2k)(514.8k)(291.5k)(315.2k)(299.7k)(353.9k)(295.6k)(314.5k)(405.6k)(132.7k)(162.8k)(167.3k)(191.7k)(156.4k)(199.4k)

EBIT margin, %

(1269%)(480%)(176%)(280%)(346%)(259%)(259%)(151%)(277%)(236%)(131%)(185%)(160%)(210%)(129%)(77%)(97%)(70%)(115%)(78%)(97%)(134%)(29%)(46%)(39%)(55%)(45%)(82%)

Interest expense

39.6k32.3k31.6k31.7k35.5k42.9k46.9k22.7k205.2k569.2k845.1k115.9k37.8k2.4k13.9k16.7k13.1k6.8k132.8k12.1k12.9k19.5k17.5k18.0k17.9k

Interest income

10.1k

Pre tax profit

(1.8m)(1.1m)(783.4k)(797.7k)(662.7k)(724.2k)(420.3k)(506.8k)(527.6k)(305.4k)(331.9k)(312.8k)(360.7k)(428.4k)(326.6k)(418.6k)(152.2k)180.3k185.3k209.6k174.9k219.1k

Income tax expense

Net Income

(1.8m)(1.1m)(783.4k)(797.7k)(792.1k)(662.7k)(647.8k)(506.9k)(788.0k)(1.3m)(1.3m)(724.2k)(420.3k)(506.8k)(527.6k)(305.4k)(331.9k)(312.8k)(360.7k)(428.4k)(326.6k)(418.6k)(152.2k)(180.3k)(185.3k)(209.6k)(174.9k)(248.9k)

Vycor Medical Balance Sheet

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Cash

2.2m1.8m406.0k169.7k263.7k15.9k20.2k944.02.7m2.8m2.4m1.3m103.6k87.7k114.2k561.5k518.8k315.0k101.9k76.7k90.1k101.1k63.0k98.5k70.7k71.0k

Accounts Receivable

106.2k113.6k314.7k171.8k140.8k83.6k92.2k199.7k289.0k196.9k151.9k166.0k116.8k247.7k117.9k238.1k130.5k136.3k245.2k260.0k295.0k214.8k163.0k97.0k

Prepaid Expenses

1.2m1.2m537.7k265.8k225.5k363.9k301.6k223.8k238.0k178.1k295.7k244.5k104.5k105.4k84.4k87.6k118.2k76.6k99.9k154.4k76.9k116.0k107.1k75.9k

Inventories

67.2k118.2k312.0k329.4k322.0k268.0k259.1k254.1k228.4k239.7k261.5k310.7k277.4k239.7k223.1k186.5k175.0k212.2k201.0k182.3k218.3k254.4k252.8k226.6k201.1k193.6k

Current Assets

3.5m3.2m1.6m936.7k951.9k731.4k673.1k753.5k3.5m3.5m3.2m2.0m654.5k638.8k558.6k1.1m896.1k853.0k551.6k472.0k653.5k769.8k687.7k656.0k541.9k444.5k

PP&E

711.7k671.6k989.2k941.3k881.7k774.4k721.8k728.3k674.6k642.7k623.0k530.4k501.8k457.7k417.7k475.2k462.1k502.5k470.1k473.8k445.5k363.5k351.2k353.7k408.6k390.6k

Total Assets

4.8m4.4m3.4m2.7m2.7m2.3m2.2m2.3m4.9m4.8m4.5m3.2m1.8m1.7m1.5m2.1m1.8m1.7m1.4m1.3m1.4m1.2m1.1m1.1m1.1m1.0m

Accounts Payable

233.0k241.9k192.7k157.3k307.1k214.6k237.6k357.2k166.1k145.1k145.7k150.0k190.6k155.2k195.8k113.5k121.0k174.2k130.1k118.0k95.7k178.6k154.7k198.2k251.1k170.6k

Short-term debt

504.8k1.6m1.6m1.6m2.1m2.5m2.6m2.3m332.8k353.3k

Current Liabilities

1.5m2.7m3.0m3.2m3.9m4.4m4.6m5.1m2.7m950.3k880.6k891.0k1.1m1.3m969.4k1.3m1.6m1.5m1.8m2.1m2.1m2.4m2.6m2.6m

Long-term debt

1.3m1.6m2.1m151.5k108.6k19.1k7.7k111.0k100.1k

Total Debt

1.8m1.6m1.6m3.3m4.1m2.5m2.6m2.3m151.5k108.6k630.6k664.3k19.1k7.7k443.7k453.5k

Total Liabilities

2.8m2.7m5.1m3.3m1.0m

Common Stock

80.5k80.6k83.8k87.0k85.3k603.0654.0667.01.0k1.1k1.1k1.1k1.1k1.8k2.0k2.0k2.0k2.2k2.3k2.4k2.4k2.5k2.6k2.6k

Preferred Stock

1.01.01.01.01.01.01.024.024.027.027.027.027.027.027.027.027.027.027.027.027.0

Additional Paid-in Capital

11.5m12.5m12.7m12.7m12.8m13.2m13.5m13.6m17.6m20.6m23.8m24.1m24.7m24.8m24.9m26.3m26.7m26.9m27.0m27.5m27.6m27.9m28.0m28.2m28.4m28.6m

Retained Earnings

(9.7m)(10.8m)(12.4m)(13.2m)(14.0m)(15.3m)(15.9m)(16.4m)(17.8m)(19.1m)(20.4m)(21.9m)(23.9m)(24.3m)(24.7m)(25.6m)(26.0m)(26.6m)(27.5m)(27.9m)(28.2m)(29.0m)(29.2m)(29.6m)(30.1m)(30.4m)

Total Equity

1.9m1.7m383.4k(445.8k)(1.2m)(2.1m)(2.4m)(2.8m)(247.3k)1.5m3.4m2.4m872.9k657.8k399.1k750.8k854.0k411.9k(290.2k)(239.8k)(419.9k)(977.8k)(1.0m)(1.3m)(1.6m)(1.7m)

Debt to Equity Ratio

0.9 x0.9 x4.3 x-7.3 x-3.5 x-1.2 x-1.1 x-0.8 x-0.6 x0.1 x0 x0 x

Debt to Assets Ratio

0.4 x0.4 x0.5 x1.2 x1.5 x1.1 x1.2 x1 x0 x0 x0 x0 x

Financial Leverage

2.4 x2.5 x8.9 x-6.1 x-2.3 x-1.1 x-0.9 x-0.8 x-19.7 x3.2 x1.3 x1.4 x2 x2.6 x3.9 x2.8 x2.1 x4.2 x-4.7 x-5.3 x-3.4 x-1.2 x-1.1 x-0.9 x-0.7 x-0.6 x

Vycor Medical Cash Flow

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Net Income

(2.8m)(3.9m)(783.4k)(1.6m)(2.4m)(662.7k)(1.3m)(1.8m)(788.0k)(2.1m)(3.3m)(724.2k)(1.1m)(1.7m)(527.6k)(832.9k)(1.2m)(312.8k)(673.5k)(1.1m)(326.6k)(745.2k)(897.4k)(180.3k)(365.6k)(575.2k)(174.9k)(423.8k)

Depreciation and Amortization

101.8k155.4k81.6k164.2k248.9k86.3k175.5k286.2k97.2k200.7k297.9k85.3k174.1k269.3k65.6k134.3k200.7k73.1k146.3k222.6k45.3k90.1k136.2k18.0k35.1k52.4k16.2k30.4k

Accounts Receivable

(29.6k)(37.1k)(440.0)141.4k172.8k60.2k51.9k(129.9k)(76.4k)15.8k60.8k(43.9k)10.3k11.1k(56.0k)(116.3k)(10.5k)(98.9k)30.9k(89.3k)(20.1k)(25.9k)(134.7k)(2.5k)(37.6k)42.7k115.0k177.6k

Inventories

(14.5k)(65.7k)(127.7k)(145.5k)(138.0k)22.5k31.3k36.5k(21.4k)(32.7k)(54.6k)17.4k35.6k52.3k12.6k50.3k61.8k15.0k26.5k(10.7k)12.9k31.5k(7.6k)(54.4k)(55.9k)(32.9k)6.3k8.5k

Accounts Payable

116.5k126.9k16.1k(18.6k)130.9k27.0k49.9k169.3k(80.8k)(68.7k)(108.2k)(69.8k)(97.1k)(39.9k)(59.8k)(95.2k)(54.6k)(136.4k)(129.0k)(75.8k)(11.2k)(23.3k)(45.6k)85.6k61.7k105.2k(780.0)(74.8k)

Cash From Operating Activities

(1.4m)(2.4m)(385.2k)(713.4k)(1.1m)(263.7k)(551.1k)(639.6k)(1.1m)(1.8m)(2.2m)(527.9k)(751.9k)(1.1m)(200.1k)(382.9k)(385.7k)(242.8k)(249.5k)(351.2k)(144.7k)(250.1k)(286.1k)(18.1k)(32.1k)85.4k(32.8k)(79.1k)

Purchases of PP&E

(16.1k)(22.9k)(8.0k)(17.6k)(20.2k)(10.1k)(20.1k)(88.8k)(29.6k)(62.0k)(107.6k)(12.5k)(26.5k)(47.1k)(17.2k)(20.2k)(28.3k)(71.3k)(88.0k)(160.3k)(13.2k)(50.0k)(56.6k)(6.3k)(8.2k)(25.1k)(47.4k)(50.0k)

Capital Expenditures

(3.4k)

Cash From Investing Activities

(75.9k)(82.7k)(158.0k)(187.4k)(230.1k)(139.1k)(217.7k)(320.8k)(40.6k)(82.0k)(141.7k)(78.8k)(96.0k)(131.4k)(17.2k)(20.2k)(28.3k)(71.3k)(88.0k)(160.3k)(13.2k)(50.0k)(56.6k)(6.3k)(8.2k)(25.1k)(47.4k)(50.4k)

Short-term Borrowings

(81.6k)(272.4k)(9.1k)(26.5k)(34.7k)(12.1k)(28.2k)(53.0k)(126.9k)(186.7k)(198.6k)(25.3k)(40.3k)(68.9k)(25.8k)(39.5k)(64.5k)(23.4k)(37.7k)(65.0k)

Cash From Financing Activities

3.6m4.2m(5.3k)108.3k601.5k340.6k719.1k917.6k3.8m4.7m4.8m8.5k(40.3k)(68.9k)(25.8k)145.5k183.5k818.8k804.5k777.2k55.2k167.7k221.5k39.7k17.6k(49.1k)78.9k139.8k

Net Change in Cash

2.1m1.7m(544.8k)(781.2k)(687.2k)(43.9k)(39.6k)(58.9k)2.7m2.8m2.4m(606.4k)(880.9k)(1.3m)(243.9k)(259.8k)(233.3k)504.7k461.9k258.2k(104.3k)(129.5k)(116.1k)14.6k(23.5k)12.0k(1.5k)10.3k

Interest Paid

1.6k197.0197.0197.088.0143.9k430.2k430.2k

Income Taxes Paid

Free Cash Flow

(2.4m)

Vycor Medical Ratios

USDQ2, 2011

Debt/Equity

0.9 x

Debt/Assets

0.4 x

Financial Leverage

2.4 x